PRXL2C Gene

Name peroxiredoxin like 2C
Description Involved in positive regulation of ERK1 and ERK2 cascade and positive regulation of glycolytic process. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have identified MFSD2B, a member of the major facilitator superfamily, as a critical exporter of sphingosine‐1‐phosphate (S1P) in hematopoietic cells. Investigations in erythroid cell‐derived models have shown that MFSD2B mediates the export of S1P into the bloodstream, with gene knockout experiments leading to markedly reduced S1P release. In addition, a closely related protein, MFSD2A, which shares a conserved 12-transmembrane domain structure, has been characterized in various tissues—its expression being modulated under metabolic stresses such as fasting and cold-induced thermogenesis—pointing to a broader functional family involved in lipid transport."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n\nDissecting the mechanistic details reveals that MFSD2B utilizes a proton gradient to drive the export of S1P. In erythrocytes and platelets alike, resting cells accumulate S1P intracellularly; however, upon activation, S1P is mobilized to the plasma membrane where MFSD2B functions to export it. Key residues within MFSD2B, such as D95 and T157, are indispensable for this transport activity. In platelets, loss of MFSD2B leads not only to sphingolipid accumulation but also to significant alterations in morphology and function, which manifest as impaired thrombus formation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n\nThe physiological impact of MFSD2B-mediated S1P export is profound, extending to the integrity of blood vessels and cardioprotection. Studies combining deletion of MFSD2B with other S1P transporters, such as SPNS2, demonstrate that S1P export is essential for proper vascular development and homeostasis—with deficiencies resulting in severe hemorrhage and compromised vascular barriers. Moreover, platelet-derived S1P has been shown to exert cardioprotective effects during acute myocardial infarction, suggesting that MFSD2B and its regulated S1P release represent promising targets for therapeutic intervention in thrombotic and cardiovascular disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Martin Angers, Marc Uldry, Dong Kong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mfsd2a encodes a novel major facilitator superfamily domain-containing protein highly induced in brown adipose tissue during fasting and adaptive thermogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20080165"}], "href": "https://doi.org/10.1042/BJ20080165"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18694395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18694395"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Naoki Kobayashi, Shoko Kawasaki-Nishi, Masato Otsuka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-23300-x"}], "href": "https://doi.org/10.1038/s41598-018-23300-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29563527"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29563527"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Toan Q Nguyen, Thiet Minh Vu, Farhana Tukijan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Erythrocytes efficiently utilize exogenous sphingosines for S1P synthesis and export via Mfsd2b."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA120.012941"}], "href": "https://doi.org/10.1074/jbc.RA120.012941"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33334894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33334894"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Madhuvanthi Chandrakanthan, Toan Quoc Nguyen, Zafrul Hasan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deletion of Mfsd2b impairs thrombotic functions of platelets."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-021-22642-x"}], "href": "https://doi.org/10.1038/s41467-021-22642-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33863882"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33863882"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Thanh Nha Uyen Le, Toan Q Nguyen, Pazhanichamy Kalailingam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mfsd2b and Spns2 are essential for maintenance of blood vessels during development and in anaphylactic shock."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2022.111208"}], "href": "https://doi.org/10.1016/j.celrep.2022.111208"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35977478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35977478"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Amin Polzin, Lisa Dannenberg, Marcel Benkhoff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-023-38069-5"}], "href": "https://doi.org/10.1038/s41467-023-38069-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37100836"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37100836"}]}]}]}
NCBI Gene ID 195827
API
Download Associations
Predicted Functions View PRXL2C's ARCHS4 Predicted Functions.
Co-expressed Genes View PRXL2C's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View PRXL2C's ARCHS4 Predicted Functions.

Functional Associations

PRXL2C has 1,220 functional associations with biological entities spanning 5 categories (functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 23 datasets.

Click the + buttons to view associations for PRXL2C from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of PRXL2C gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of PRXL2C gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of PRXL2C gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with PRXL2C protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of PRXL2C protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by PRXL2C gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with PRXL2C gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
GO Biological Process Annotations 2023 biological processes involving PRXL2C gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving PRXL2C gene from the curated GO Biological Process Annotations2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of PRXL2C gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of PRXL2C gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of PRXL2C gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of PRXL2C gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of PRXL2C gene from the NIBR DRUG-seq U2OS MoA Box dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of PRXL2C gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of PRXL2C gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of PRXL2C gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of PRXL2C gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of PRXL2C gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of PRXL2C gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of PRXL2C gene from the Sci-Plex Drug Perturbation Signatures dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of PRXL2C protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with PRXL2C protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.